Anxiety Med Recalled

The presence of foreign tablets or capsules in bottles has led Oxford Pharmaceuticals to recall a single lot of buspirone hydrochloride tablets. The recall was listed in the June 9, 2021, US Food and Drug Administration (FDA) Enforcement Report. 

Recalled are 6864 bottles of 15-mg buspirone hydrochloride tablets in 100-count bottles (NDC 69584-093-10) from lot C21021A (Exp. 3/23). The drug was manufactured by Oxford Pharmaceuticals, LLC, Birmingham, AL, and distributed throughout the United States. 

Oxford Pharmaceuticals voluntarily initiated the recalls May 5, 2021. The FDA designated the recall Class II on June 2, 2021. Drugs affected by Class II recalls may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm also exists. 

Buspirone is a prescription anxiolytic used to treat anxiety.